Shuhart Christopher, Cheung Angela, Gill Ranjodh, Gani Linsey, Goel Heenam, Szalat Auryan
Swedish Bone Health and Osteoporosis Center, Swedish Medical Group, Seattle, WA, USA.
Centre of Excellence in Skeletal Health Assessment, University of Toronto, Toronto, Ontario, Canada; Osteoporosis Program, University Health Network and Sinai Health System, Toronto, Ontario, Canada.
J Clin Densitom. 2024 Jan-Mar;27(1):101435. doi: 10.1016/j.jocd.2023.101435. Epub 2023 Oct 31.
After 15 months of preparation by task force chairs and teams, ISCD's 9th Position Development Conference (PDC) convened in Northbrook, IL, USA on March 28th and 29th, 2023 to approve new ISCD Official Positions in the topic areas of DXA Reporting, Follow-up BMD Testing and TBS Application and Reporting. Three teams of participants work to bring the PDC to fruition: the Steering Committee, Task Forces and Chairs, and the Expert Panel. To reach agreement on draft Official Positions, the PDC follows a scripted process with the UCLA/RAND Appropriateness Method (UCLA/RAM) as its foundation. Multiple rounds of data review, public debate and voting resulted in 32 new or modified Official Positions. Six companion position papers are also published along with this Executive Summary, serving as the detailed substantiation for the Official Positions. This Executive Summary reviews the personnel groups, activities and products of the 2023 PDC, with the entirety of the updated 2023 Official Positions presented in Appendix A. New Official Positions are highlighted in bold.
在特别工作组主席和团队经过15个月的筹备后,国际临床骨密度学会(ISCD)第九届立场发展会议(PDC)于2023年3月28日至29日在美国伊利诺伊州北布鲁克召开,以批准在双能X线吸收法(DXA)报告、骨密度(BMD)随访检测以及骨小梁评分(TBS)应用与报告等主题领域的新ISCD官方立场。三组参与者共同努力促成了此次PDC会议:指导委员会、特别工作组及其主席,以及专家小组。为就官方立场草案达成一致,PDC会议以加州大学洛杉矶分校/兰德适用性方法(UCLA/RAM)为基础,遵循既定流程。经过多轮数据审查、公开辩论和投票,最终产生了32项新的或经过修订的官方立场。六篇配套立场文件也与本执行摘要一同发表,作为官方立场的详细依据。本执行摘要回顾了2023年PDC会议的人员组成、活动和成果,更新后的2023年官方立场全文载于附录A。新的官方立场以粗体突出显示。